1. Home
  2. WGS vs UPBD Comparison

WGS vs UPBD Comparison

Compare WGS & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGS
  • UPBD
  • Stock Information
  • Founded
  • WGS 2017
  • UPBD 1986
  • Country
  • WGS United States
  • UPBD United States
  • Employees
  • WGS N/A
  • UPBD N/A
  • Industry
  • WGS Retail: Computer Software & Peripheral Equipment
  • UPBD Diversified Commercial Services
  • Sector
  • WGS Technology
  • UPBD Consumer Discretionary
  • Exchange
  • WGS Nasdaq
  • UPBD Nasdaq
  • Market Cap
  • WGS 2.0B
  • UPBD 1.6B
  • IPO Year
  • WGS N/A
  • UPBD 1995
  • Fundamental
  • Price
  • WGS $92.20
  • UPBD $23.74
  • Analyst Decision
  • WGS Strong Buy
  • UPBD Buy
  • Analyst Count
  • WGS 5
  • UPBD 4
  • Target Price
  • WGS $82.60
  • UPBD $37.00
  • AVG Volume (30 Days)
  • WGS 707.5K
  • UPBD 571.5K
  • Earning Date
  • WGS 04-28-2025
  • UPBD 05-01-2025
  • Dividend Yield
  • WGS N/A
  • UPBD 6.57%
  • EPS Growth
  • WGS N/A
  • UPBD N/A
  • EPS
  • WGS N/A
  • UPBD 2.21
  • Revenue
  • WGS $305,450,000.00
  • UPBD $4,320,564,000.00
  • Revenue This Year
  • WGS $18.58
  • UPBD $8.46
  • Revenue Next Year
  • WGS $17.65
  • UPBD $6.87
  • P/E Ratio
  • WGS N/A
  • UPBD $10.74
  • Revenue Growth
  • WGS 50.79
  • UPBD 8.22
  • 52 Week Low
  • WGS $8.53
  • UPBD $23.35
  • 52 Week High
  • WGS $115.60
  • UPBD $38.72
  • Technical
  • Relative Strength Index (RSI)
  • WGS 48.23
  • UPBD 35.77
  • Support Level
  • WGS $93.40
  • UPBD $24.01
  • Resistance Level
  • WGS $107.98
  • UPBD $25.60
  • Average True Range (ATR)
  • WGS 6.97
  • UPBD 0.76
  • MACD
  • WGS -0.87
  • UPBD 0.11
  • Stochastic Oscillator
  • WGS 27.49
  • UPBD 12.34

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: